 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 1186 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Pittsburgh, PA USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Dallas, TX USA |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
New York, NY USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Edison, NJ USA |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Orlando, FL USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Chicago, IL |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Scarborough, ME USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Danville, PA USA |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Graz, Austria |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Kiel, Germany |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Hamburg, Germany |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Tel Aviv, Israel |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Milan, Italy |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
Milan, Italy |
 |
09/30/2009 |
 |
 |
 |
Details |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
San Diego, CA USA |
 |
09/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC USA |
 |
09/05/2009 |
 |
 |
 |
Details |
 |
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Atlanta, GA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Salt Lake City, UT USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
New York, NY USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Houston, TX USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Chicago, IL USA |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
 |
Lebanon, NH USA |
 |
08/11/2009 |
 |
 |
 |
 |
 |